|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000138308 |
Summary for PLA2G12B |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000138308 | Gene symbol | PLA2G12B |
| Gene name | phospholipase A2 group XIIB | |
| HGNC | 18555 | |
| Entrez ID | 84647 | |
| Gene type | protein_coding | |
| Synonyms | PLA2G12B| | |
| UniProtAcc | Q9BX93 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PLA2G12B |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PLA2G12B | 1.41e+02 | -2.61e+00 | 6.50e-01 | -4.01e+00 | 5.97e-05 | 2.30e-04 | STAD |
| PLA2G12B | 1.14e+02 | -2.19e+00 | 6.00e-01 | -3.65e+00 | 2.62e-04 | 6.16e-04 | KIRP |
| PLA2G12B | 7.48e+02 | -4.72e+00 | 9.62e-01 | -4.91e+00 | 9.24e-07 | 6.68e-06 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PLA2G12B | 1.59e+02 | -1.33e+00 | 5.55e-01 | -2.41e+00 | 1.61e-02 | 2.69e-02 | COAD |
Top |
Sex-biased somatic mutation for PLA2G12B |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PLA2G12B |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg02044879 | chr10:72955177 | CGI:chr10:73096100-73097227 | promoter | 8.74e-01 | 7.67e-01 | 2.22e+00 | 2.66e-02 | 3.90e-02 | 1.07e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg07580789 | chr10:72953702 | CGI:chr10:73096100-73097227 | promoter,gene body | 6.36e-01 | 7.39e-01 | -2.68e+00 | 7.31e-03 | 9.04e-03 | -1.03e-01 |
| HNSC | cg07580789 | chr10:72953702 | CGI:chr10:73096100-73097227 | promoter,gene body | 6.47e-01 | 7.70e-01 | -3.05e+00 | 2.32e-03 | 3.71e-03 | -1.23e-01 |
| HNSC | cg10410852 | chr10:72954550 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 7.25e-01 | 8.41e-01 | -3.04e+00 | 2.36e-03 | 3.76e-03 | -1.17e-01 |
| HNSC | cg21820890 | chr10:72954617 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 7.48e-01 | 8.54e-01 | -3.04e+00 | 2.38e-03 | 3.78e-03 | -1.06e-01 |
| LUSC | cg10842126 | chr10:72954987 | CGI:chr10:73096100-73097227 | promoter | 7.88e-01 | 5.78e-01 | 3.82e+00 | 1.36e-04 | 8.00e-04 | 2.11e-01 |
| LUSC | cg02044879 | chr10:72955177 | CGI:chr10:73096100-73097227 | promoter | 7.96e-01 | 6.30e-01 | 3.26e+00 | 1.10e-03 | 2.76e-03 | 1.67e-01 |
| COAD | cg07580789 | chr10:72953702 | CGI:chr10:73096100-73097227 | promoter,gene body | 6.56e-01 | 8.56e-01 | -2.23e+00 | 2.60e-02 | 3.03e-02 | -2.00e-01 |
| COAD | cg10410852 | chr10:72954550 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 6.21e-01 | 8.53e-01 | -2.23e+00 | 2.60e-02 | 3.03e-02 | -2.32e-01 |
| COAD | cg21820890 | chr10:72954617 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 6.41e-01 | 8.74e-01 | -2.64e+00 | 8.37e-03 | 1.25e-02 | -2.33e-01 |
| BLCA | cg02044879 | chr10:72955177 | CGI:chr10:73096100-73097227 | promoter | 6.28e-01 | 7.91e-01 | -2.03e+00 | 4.25e-02 | 4.41e-02 | -1.64e-01 |
| LIHC | cg07580789 | chr10:72953702 | CGI:chr10:73096100-73097227 | promoter,gene body | 3.63e-01 | 5.05e-01 | -4.78e+00 | 1.74e-06 | 5.98e-06 | -1.42e-01 |
| LIHC | cg10410852 | chr10:72954550 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 3.61e-01 | 4.71e-01 | -4.21e+00 | 2.54e-05 | 6.17e-05 | -1.10e-01 |
| LIHC | cg21820890 | chr10:72954617 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 4.11e-01 | 5.20e-01 | -5.00e+00 | 5.81e-07 | 2.33e-06 | -1.09e-01 |
| LIHC | cg02044879 | chr10:72955177 | CGI:chr10:73096100-73097227 | promoter | 3.36e-01 | 4.50e-01 | -4.19e+00 | 2.76e-05 | 6.64e-05 | -1.15e-01 |
| CHOL | cg07580789 | chr10:72953702 | CGI:chr10:73096100-73097227 | promoter,gene body | 7.56e-01 | 4.07e-01 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 3.50e-01 |
| CHOL | cg10410852 | chr10:72954550 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 7.79e-01 | 4.39e-01 | 3.02e+00 | 2.51e-03 | 1.19e-02 | 3.40e-01 |
| CHOL | cg21820890 | chr10:72954617 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 8.10e-01 | 4.93e-01 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 3.18e-01 |
| CHOL | cg10842126 | chr10:72954987 | CGI:chr10:73096100-73097227 | promoter | 7.42e-01 | 4.47e-01 | 3.02e+00 | 2.51e-03 | 1.19e-02 | 2.95e-01 |
| CHOL | cg02044879 | chr10:72955177 | CGI:chr10:73096100-73097227 | promoter | 7.71e-01 | 4.06e-01 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 3.65e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg02044879 | chr10:72955177 | CGI:chr10:73096100-73097227 | promoter | 5.11e-01 | 6.14e-01 | -2.16e+00 | 3.05e-02 | 3.50e-02 | -1.03e-01 |
| KIRP | cg10410852 | chr10:72954550 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 8.09e-01 | 6.71e-01 | 2.60e+00 | 9.43e-03 | 1.62e-02 | 1.38e-01 |
| KIRP | cg21820890 | chr10:72954617 | CGI:chr10:73096100-73097227 | promoter,exon,CDS,gene body | 8.12e-01 | 7.06e-01 | 2.28e+00 | 2.26e-02 | 2.91e-02 | 1.06e-01 |
Top |
Exon skipping events with PSI in TCGA for PLA2G12B |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PLA2G12B |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PLA2G12B |
| TFs related to PLA2G12B. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | ZNF454 | PLA2G12B | 4.87e+00 | 9.82e-01 | 4.17e+00 | 1.53e-02 | Male-biased |
| ACC | ZNF530 | PLA2G12B | 4.68e+00 | 9.81e-01 | 3.97e+00 | 1.45e-02 | Male-biased |
| ACC | ZNF611 | PLA2G12B | 4.79e+00 | 9.91e-01 | 3.84e+00 | 5.32e-03 | Male-biased |
| ACC | ZNF765 | PLA2G12B | 4.72e+00 | 9.83e-01 | 3.99e+00 | 1.37e-02 | Male-biased |
| ACC | ZNF792 | PLA2G12B | 4.73e+00 | 9.81e-01 | 4.02e+00 | 1.49e-02 | Male-biased |
| SARC | ZNF235 | PLA2G12B | 4.90e+00 | 9.85e-01 | 4.36e+00 | 1.16e-02 | Male-biased |
| PLA2G12B related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PLA2G12B |
| RBPs related to ES in PLA2G12B. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PLA2G12B related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs55818842 | chr10:66670727:A:C | - | 0.281309482400937 | 0.000172000457060976 | KIRP | Female-baised eQTL |
| rs10998731 | chr10:69342977:G:A | - | 0.354045342160174 | 0.00173033820916995 | KIRP | Female-baised eQTL |
| rs10998724 | chr10:69338620:T:G | - | 0.353591679951164 | 0.00181894036297395 | KIRP | Female-baised eQTL |
| rs61863042 | chr10:82275321:G:A | - | 0.215424497238202 | 0.00259774170001085 | KIRP | Female-baised eQTL |
| rs12783362 | chr10:78780746:G:A | - | 0.30443937356192 | 0.00448356221923676 | KIRP | Female-baised eQTL |
| rs737109 | chr10:78783319:G:A | - | 0.303920871956012 | 0.00471217655227485 | KIRP | Female-baised eQTL |
| rs10998733 | chr10:69347582:C:T | - | 0.359688799651974 | 0.00620029476533796 | KIRP | Female-baised eQTL |
| rs61863039 | chr10:82269275:A:G | - | 0.19429896756835 | 0.0112945193604478 | KIRP | Female-baised eQTL |
| rs77509458 | chr10:78786308:A:T | - | 0.268918108941725 | 0.0206103338627429 | KIRP | Female-baised eQTL |
| rs7075537 | chr10:78785625:A:G | - | 0.268405303551115 | 0.021698274237342 | KIRP | Female-baised eQTL |
| rs142519593 | chr10:66429682:G:C | - | 0.146420969286552 | 0.0241823585723888 | KIRP | Female-baised eQTL |
| rs77521063 | chr10:66433794:T:C | - | 0.146420969286552 | 0.0241823585723888 | KIRP | Female-baised eQTL |
| rs4746591 | chr10:66450955:G:A | - | 0.146420969286552 | 0.0241823585723888 | KIRP | Female-baised eQTL |
| rs12268022 | chr10:77364655:C:T | - | 0.149740167869822 | 0.0241823585723888 | KIRP | Female-baised eQTL |
| rs61867239 | chr10:66461898:C:T | - | 0.138175819121697 | 0.0346068900904854 | KIRP | Female-baised eQTL |
| rs7917556 | chr10:66463287:C:T | - | 0.138175819121697 | 0.0346068900904854 | KIRP | Female-baised eQTL |
| rs12359000 | chr10:71189978:G:A | - | 0.148823477221166 | 0.0378795000146483 | KIRP | Female-baised eQTL |
| rs7080430 | chr10:71188820:C:T | - | 0.145587409891419 | 0.0463532270645751 | KIRP | Female-baised eQTL |
| rs7069026 | chr10:71189207:A:C | - | 0.145587409891419 | 0.0463532270645751 | KIRP | Female-baised eQTL |
| rs6480500 | chr10:71195066:A:G | - | 0.145587409891419 | 0.0463532270645751 | KIRP | Female-baised eQTL |
| rs7074151 | chr10:71197469:G:C | - | 0.145587409891419 | 0.0463532270645751 | KIRP | Female-baised eQTL |
| rs7078728 | chr10:71198452:C:G | - | 0.145587409891419 | 0.0463532270645751 | KIRP | Female-baised eQTL |
| rs35177325 | chr10:66420352:A:G | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs61867354 | chr10:66421700:G:A | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs68118260 | chr10:66422014:T:A | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs12783614 | chr10:66426268:G:C | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs146363874 | chr10:66429503:A:G | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs34247065 | chr10:66431325:G:C | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs56239371 | chr10:66436173:G:A | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs34129307 | chr10:66438205:C:T | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs12781320 | chr10:66438553:C:G | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs4492695 | chr10:66441785:A:G | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs150532465 | chr10:66443433:C:T | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs140200294 | chr10:66443939:G:A | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs144439858 | chr10:66446633:G:A | - | 0.134880654200557 | 0.0483108723011703 | KIRP | Female-baised eQTL |
| rs10998725 | chr10:69339439:G:A | - | 0.26528796470691 | 0.04860662032191 | KIRP | Female-baised eQTL |
| rs10998726 | chr10:69339466:G:T | - | 0.26528796470691 | 0.04860662032191 | KIRP | Female-baised eQTL |
| rs11188500 | chr10:81125785:T:C | - | 0.112155684989359 | 0.0224867350282201 | STAD | Female-baised eQTL |
| rs61853685 | chr10:81473721:C:T | - | 0.080421254576701 | 0.0432928520266243 | LUAD | Female-baised eQTL |
| rs10824612 | chr10:78462986:G:C | - | 0.0706863691947147 | 0.0145952552243566 | COAD | Female-baised eQTL |
| rs11002568 | chr10:78463819:T:G | - | 0.0678539224958015 | 0.0184795174105742 | COAD | Female-baised eQTL |
| rs3858129 | chr10:64736382:G:A | - | -0.068596654262318 | 0.0376997714892903 | COAD | Female-baised eQTL |
| rs4746471 | chr10:64749024:C:T | - | -0.0720181770621198 | 0.0412743084047434 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9663999 | chr10:81250996:C:T | - | 0.074030380283587 | 0.0284352529827568 | LIHC | Male-baised eQTL |
| rs7914081 | chr10:79170247:C:G | - | -0.0733963465477148 | 0.0242801615178965 | KIRC | Male-baised eQTL |
| rs17600642 | chr10:70703238:C:A | - | 0.0560409223387556 | 0.0102729178600692 | LUAD | Male-baised eQTL |
| rs297044 | chr10:69553193:A:T | - | -0.0564368977972901 | 0.0492310731372276 | LUAD | Male-baised eQTL |
| rs10822744 | chr10:66192988:G:T | - | -0.0698096043312325 | 0.0050642988773251 | COAD | Male-baised eQTL |
| rs7908442 | chr10:66188438:T:C | - | -0.0696437175323492 | 0.0052508417099459 | COAD | Male-baised eQTL |
| rs1462815 | chr10:66186018:A:G | - | -0.0695678441857823 | 0.00533136329765341 | COAD | Male-baised eQTL |
| rs4746554 | chr10:66200705:C:T | - | -0.069961737411848 | 0.00533284492349916 | COAD | Male-baised eQTL |
| rs1995666 | chr10:80891645:T:C | - | -0.0657783040697189 | 0.0136658957497466 | COAD | Male-baised eQTL |
| rs7904398 | chr10:66194435:C:T | - | -0.060797309639191 | 0.0274668415278321 | COAD | Male-baised eQTL |
| rs1248640 | chr10:77860298:G:T | - | -0.0569583102625933 | 0.0448024041890092 | COAD | Male-baised eQTL |
| rs1248651 | chr10:77875856:C:T | - | -0.0567168790326441 | 0.0464366121711804 | COAD | Male-baised eQTL |
| rs1248677 | chr10:77847334:G:A | - | -0.0566795723336339 | 0.0470531670261092 | COAD | Male-baised eQTL |
| rs1248672 | chr10:77844821:C:T | - | -0.0566946249084697 | 0.0474600135131233 | COAD | Male-baised eQTL |
| rs1248663 | chr10:77830968:C:G | - | -0.0562605921928556 | 0.0477304738963821 | COAD | Male-baised eQTL |
| rs75014788 | chr10:81830526:A:C | - | 0.0760960891474224 | 0.0499039347241492 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000138308 |
| CpG Site: cg10842126 | |
| Position to Gene: promoter | |
| Male Effect: -0.236198527314891 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg10842126 | chr10:72954987 | promoter | -0.236198527314891 | 1.51794818286228e-09 | -0.45181394500902083 | 1.287381922068013e-12 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PLA2G12B |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
